Skip to main content
    C

    Crispr Therapeutics AG (CRSP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $40.15
    -0.22 (-0.55%)

    Market Cap: $4.10B

    Last updated: Nov 17, 2026 at 4:36 PM ET

    Crispr Therapeutics AG (CRSP) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Crispr Therapeutics AG (CRSP) has a latest price of $40.15 on Nov 17, 2026, 36.7% below its 52-week high of $63.45. Its price fell 23.6% over the past 12 months. The month-end price rose 181.8% over the 10 years through Oct 2026, a compound annual rate of 10.9%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $165.70 in Jan 2021 and its lowest $13.62 in May 2017, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CRSP with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CRSP.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 32.9%, and over 6 months it fell 15.6%. The month-end price rose 32.1% over the 3 years through Oct 2026, a compound annual rate of 9.7%.

    PeriodChange
    1 month-19.8%
    3 months-32.9%
    6 months-15.6%
    12 months-23.6%
    12 months, with dividends-23.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+32.1%+9.7%
    5 years-43.7%-10.9%
    10 years+181.8%+10.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 151.4%, and its weakest was 2021, when it fell 50.5%.

    YearCloseChange
    2026 through Oct 2026$51.42-1.9%
    2025$52.44+33.2%
    2024$39.36-37.1%
    2023$62.60+54.0%
    2022$40.65-46.4%
    2021$75.78-50.5%
    2020$153.11+151.4%
    2019$60.91+113.2%
    2018$28.57+21.7%
    2017$23.48+15.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 22.0% below its 50-day average of $51.49 and 23.4% below its 200-day average of $52.42.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$40.15
    52-week high$63.45-36.7%
    52-week low$39.83+0.8%
    50-day average$51.49-22.0%
    200-day average$52.42-23.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 64.9%.

    MeasureValue
    1-year beta1.86
    Largest fall, 1 year-35.1%
    Largest fall, 3 years-64.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CRSP

    What is CRSP's 1-year price change?

    Crispr Therapeutics AG's price fell 23.6% over the past 12 months. With dividends included, the 12-month total return was -23.6%.

    What is CRSP's 5-year price change?

    Crispr Therapeutics AG's month-end price fell 43.7% over the 5 years through Oct 2026, a compound annual decline of 10.9%. These figures leave out dividends.

    What is CRSP's 52-week high and low?

    Crispr Therapeutics AG's 52-week high is $63.45 and its 52-week low is $39.83. Its latest price of $40.15 on Nov 17, 2026 is 36.7% below the high.

    What is CRSP's beta?

    Crispr Therapeutics AG's 1-year beta against the S&P 500 is 1.86, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 35.1%.

    Is the CRSP chart free?

    Yes. Advanced Charting for CRSP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.